CDK9-IN-25
CDK9-IN-25 (compound 4a) is an imidazopyrazine CDK9 inhibitor (IC50: 0.24 μM). CDK9-IN-25 has good affinity to the main protease of COVID-19 and has antiviral activity against human coronavirus 229E (IC50: 63.28 μM).
Nos produits utilisent uniquement pour la recherche. Nous ne vendons pas aux patients.
- Formule: C15H16FN5
- Masse moléculaire:285.32
-
Stockage:
Please store the product under the recommended conditions in the Certificate of Analysis.
Activité biologique
IC50: 0.24 μM (CDK9), 63.28 μM (human Coronavirus 229E)[1]
Chemical Information
-
Masse moléculaire 285.32
-
Formule C15H16FN5
-
SMILES
CC(C)(C)NC1=C(N=C2N1C=CN=C2)C3=CC(F)=NC=C3
-
Livraison
Room temperature in continental US; may vary elsewhere.
-
Stockage
Please store the product under the recommended conditions in the Certificate of Analysis.
Pureté et documentation
Références
Calculators
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)